info@allievapharma.com

  • 24/7
    Customer Service
  • ISO 9001
    Certification Company
  • WHO-GMP
    Certified Company
OUR CATALOGUE OUR CATALOGUE

    • All Products

    OUR PRODUCTS

    Allieva Pharma offers a wide range of pharmaceutical products including tablets, capsules, and injections. Our products are manufactured with high-quality standards and trusted across India and international markets.

    TREXLIEVA 50MG Methotrexate Injection IP 50mg by Allieva Pharma Private Limited

    TREXLIEVA 50MG

    Methotrexate Injection IP 50mg

    TREXLIEVA 50 mg contains Methotrexate, an antimetabolite and antifolate chemotherapeutic agent. It inhibits dihydrofolate reductase (DHFR), leading to reduced DNA synthesis and cell replication, particularly in rapidly dividing cells. It is widely used in oncology, autoimmune diseases, and medical oncology protocols.

    View Details
    IFOSLIEVA 2G Ifosfamide for Injection with Mesna 2g by Allieva Pharma Private Limited

    IFOSLIEVA 2G

    Ifosfamide for Injection with Mesna 2g

    IFOSLIEVA 2 g contains Ifosfamide, an alkylating antineoplastic agent (nitrogen mustard derivative), supplied with Mesna. Ifosfamide causes DNA cross-linking, inhibiting DNA replication and leading to cancer cell death. Mesna is co-administered to prevent hemorrhagic cystitis by neutralizing toxic metabolites (acrolein) in the urinary tract.

    View Details
    IFOSLIEVA 1G Ifosfamide for Injection with Mesna 1g by Allieva Pharma Private Limited

    IFOSLIEVA 1G

    Ifosfamide for Injection with Mesna 1g

    IFOSLIEVA 1 g contains Ifosfamide, an alkylating antineoplastic agent (nitrogen mustard derivative), supplied with Mesna. Ifosfamide causes DNA cross-linking, inhibiting DNA replication and leading to cancer cell death. Mesna is co-administered to prevent hemorrhagic cystitis by binding toxic uro-metabolites (acrolein) in the urinary tract.

    View Details
    BORTELIEVA 3.5MG Bortezomib Injection IP 3.5mg by Allieva Pharma Private Limited

    BORTELIEVA 3.5MG

    Bortezomib Injection IP 3.5mg

    BORTLIEVA contains Bortezomib, a proteasome inhibitor used in cancer treatment. It works by blocking proteasomes in cells, leading to accumulation of proteins and apoptosis (cell death) of cancer cells.

    View Details
    BORTELIEVA 2MG Bortezomib Injection IP 2mg by Allieva Pharma Private Limited

    BORTELIEVA 2MG

    Bortezomib Injection IP 2mg

    BORTLIEVA 2 mg contains Bortezomib, a reversible proteasome inhibitor that inhibits the 26S proteasome. This leads to accumulation of misfolded proteins, disruption of cellular homeostasis, and apoptosis of malignant plasma cells. It is a key drug in multiple myeloma therapy.

    View Details
    CYTLIEVA 100MG Cytarabine Injection BP 100mg by Allieva Pharma Private Limited

    CYTLIEVA 100MG

    Cytarabine Injection BP 100mg

    CYTLIEVA 100 mg contains Cytarabine (Ara-C), a pyrimidine nucleoside analogue antimetabolite. It inhibits DNA polymerase, blocks DNA synthesis (S-phase specific), and leads to death of rapidly dividing leukemic cells. It is a cornerstone drug in acute leukemias.

    View Details
    BENDALIEVA 100MG Bendamustine Hydrochloride for Injection 100mg by Allieva Pharma Private Limited

    BENDALIEVA 100MG

    Bendamustine Hydrochloride for Injection 100mg

    BENDALIEVA 100 mg contains Bendamustine Hydrochloride, a unique alkylating antineoplastic agent with properties of both alkylating agents and purine analogues. It causes DNA cross-linking, leading to inhibition of DNA replication and cancer cell death. It is mainly used in hematological malignancies.

    View Details
    CARFLIEVA 60MG Carfilzomib for Injection 60mg by Allieva Pharma Private Limited

    CARFLIEVA 60MG

    Carfilzomib for Injection 60mg

    CARFLIEVA 60 mg contains Carfilzomib, a second-generation proteasome inhibitor. It selectively and irreversibly inhibits the 20S proteasome, leading to accumulation of abnormal proteins and apoptosis of malignant plasma cells. It is mainly used in multiple myeloma.

    View Details
    LEUCOLIEVA 300MG Leucovorin Calcium Injection USP 300mg by Allieva Pharma Private Limited

    LEUCOLIEVA 300MG

    Leucovorin Calcium Injection USP 300mg

    LEUCOLIEVA 300 mg contains Leucovorin Calcium (Folinic Acid), a biologically active reduced form of folic acid. It is used to protect normal cells from methotrexate toxicity (rescue therapy) and to enhance the antitumor activity of 5-Fluorouracil (5-FU) in colorectal and other gastrointestinal cancers.

    View Details
    LEUCOLIEVA 50MG Leucovorin Calcium Injection IP 50mg by Allieva Pharma Private Limited

    LEUCOLIEVA 50MG

    Leucovorin Calcium Injection IP 50mg

    LEUCOLIEVA 50 mg contains Leucovorin Calcium (Folinic Acid), a reduced form of folic acid. It is not a chemotherapeutic agent itself, but is used to rescue normal cells from methotrexate toxicity and to enhance the effect of 5-Fluorouracil (5-FU) in certain cancers.

    View Details
    GEMLIEVA 1000MG Gemcitabine for Injection IP 1000mg by Allieva Pharma Private Limited

    GEMLIEVA 1000MG

    Gemcitabine for Injection IP 1000mg

    GEMLIEVA 1000 mg contains Gemcitabine, a pyrimidine nucleoside analogue antimetabolite chemotherapy drug. After intracellular activation, it inhibits DNA synthesis and triggers apoptosis in rapidly dividing cancer cells.

    View Details
    GEMLIEVA 200MG Gemcitabine for Injection IP 200mg by Allieva Pharma Private Limited

    GEMLIEVA 200MG

    Gemcitabine for Injection IP 200mg

    GEMLIEVA 200 mg contains Gemcitabine, a pyrimidine nucleoside analogue antimetabolite chemotherapy drug. Inside the cell, it is phosphorylated to active metabolites that inhibit DNA synthesis and induce apoptosis of rapidly dividing cancer cells.

    View Details

    24/7 Clients Support

    Best Price

    Quality Assurance